drugset / Trial / NCT03051009
Trial Investigating the Long Term Safety and Tolerability of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
Demonstrate the safety and tolerability of desmopressin ODT during long-term treatment of subjects with nocturia due to nocturnal polyuria, for up to 1 year
Timeline
- Start
- 2017-01-11
- Primary completion
- 2018-09-11
- Completion
- 2018-09-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desmopressin | Peptide | 25 ug | Oral |
| Subject | Desmopressin | Peptide | 50 ug | Oral |
Indications
No indication recorded.